A comparative study of neuroendocrine heterogeneity in SCLC and NBL
Cai, L.; DeBerardinis, R. J.; Xie, Y.; Minna, J.; Xiao, G.
Show abstract
Lineage plasticity has long been documented in both small cell lung cancer (SCLC) and neuroblastoma (NBL), two clinically distinct neuroendocrine (NE) cancers. In this study, we quantified the NE features of cancer as NE scores and performed a systematic comparison of SCLC and NBL. We found NBL and SCLC cell lines have highly similar molecular profiles and shared therapeutic sensitivity. In addition, NE heterogeneity was observed at both the inter- and intra-cell line levels. Surprisingly, we did not find a significant association between NE scores and overall survival in SCLC or NBL. We described many shared and unique NE score-associated features between SCLC and NBL, including dysregulation of Myc oncogenes, alterations in protein expression, metabolism, drug resistance, and selective gene dependencies. Our work establishes a reference for molecular changes and vulnerabilities associated with NE to non-NE transdifferentiation through mutual validation of SCLC and NBL samples.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Systematic lncRNA mapping to genome-wide co-essential pathways uncovers cancer dependency on uncharacterized lncRNAs 95%
- Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer 95%
- An epigenetic switch regulates the ontogeny of AXL positive/EGFR-TKI resistant cells by modulating miR-335 expression 94%
Similar papers in this journal
- Pan-cancer Analysis of Homologous Recombination Deficiency in Cell Lines 94%
- Cancer relevance of circulating antibodies against LINE-1 antigens in humans 92%
- Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics 92%
Similar papers in this journal
- A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis 93%
- NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma 93%
- Proneural - Mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in Glioblastoma 93%
Similar papers in this journal
- Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells 93%
- Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics 93%
- p53 restoration in small cell lung cancer identifies a latent Cyclophilin-dependent necrosis mechanism 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.